Download the full report (112 p.) - KCE

96 Interventions in Alzheimer’s Disease KCE Reports 111
123. Wimo A, Mattson B, Krakau I, Eriksson T, Nelvig A, Karlsson G. Cost-utility analysis of group
living in dementia care. Int J Technol Assess Health Care. 1995;11(1):49-65.
124. Drummond MF, Mohide EA, Tew M, Streiner DL, Pringle DM, Gilbert JR. Economic evaluation
of a support program for caregivers of demented elderly. Int J Technol Assess Health Care.
1991;7(2):209-19.
125. Nocera S, Bonato D, Telser H. The contingency of contingent valuation. How much are people
willing to pay against Alzheimer's disease? Int J Health Care Finance Econ. 2002;2(3):219-40.
126. Brodaty H, Peters KE. Cost effectiveness of a training program for dementia carers. Int
Psychogeriatr. 1991;3(1):11-22.
127. McGuire RC. A case study in cost-effectiveness analysis for computer technology used in
support of caregivers with Alzheimer’s disease patients. Information Systems Innovations for
Nursing: New Visions and Ventures ed. Moorhead & Delaney, editor. Thousand Oaks, CA:
Sage Publications; 1998.
128. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al. Long-term donepezil
treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Lancet. 2004;363(9427):2105-15.
129. Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, et al. A populationbased
study of cholinesterase inhibitor use for dementia. J Am Geriatr Soc. 2007;55(10):1517-
23.
130. Ivanoiu A, Sindic CJM. Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive
impairment: prediction of progression to Alzheimer's disease and correlation with the
neuropsychological examination. Neurocase. 2005;11(1):32-9.